Epithalon (10mg / 50mg) appears in Aging Research catalogs for qualified buyers who need specification, COA, and RUO clarity—Epithalon Specification and Vial Format Review summarizes key checks.
Epithalon, also known as Epitalon or AEDG peptide, is a synthetic tetrapeptide used in laboratory research on cellular-aging models, peptide signaling, gene-expression pathways, and telomere-associated research systems.
Epithalon (Ala-Glu-Asp-Gly tetrapeptide) research examines telomerase reverse transcriptase (TERT) expression in human cell aging models and pineal peptide biology. Laboratory studies measure telomere length by qPCR in fibroblast replicative senescence models after peptide exposure under controlled media conditions.
Telomere repeat amplification protocol (TRAP) assays, senescence-associated β-galactosidase staining, and cell-cycle analysis by flow cytometry appear in aging-research peptide literature. Khavinson peptide research lines from St. Petersburg groups published long-term cell culture and rodent lifespan model data framed as biogerontology experiments.
Spec alignment: Enter exact strength notation (10mg / 50mg) in procurement systems—do not round kit counts. Side-by-side review of specification table, vial label, and COA prevents release errors for Epithalon.
Principal investigators should sign off Epithalon SKUs only after mechanism fit is documented in the study protocol.
Catalog identifiers for Epithalon: CAS 307297-39-8, Formula: C14H22N4O9. MW 390.35 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Publication methods should list Cat No. and mg strength for Epithalon to support reproducibility.
Dose planning for Epithalon should state mass (10mg / 50mg) or molarity derived from catalog molecular weight.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for Epithalon. QA sign-off should reference all four documents in the batch record. Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for Epithalon should state whether the lot COA must meet or exceed that threshold for your Aging Research assay type.
Specification alignment for Epithalon requires copying exact kit notation (10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits. Molecular identifiers for Epithalon—CAS 307297-39-8, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing Epithalon should include these fields for reproducibility in Aging Research journals.
Format selection for Epithalon affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Molecular identifiers for Epithalon—CAS 307297-39-8, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing Epithalon should include these fields for reproducibility in Aging Research journals. Format selection for Epithalon affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Specification alignment for Epithalon requires copying exact kit notation (10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
Epithalon from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.